Sorrento Therapeutics, Inc. (SRNE)
0.0008
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Sorrento Therapeutics Market Cap : 0.441M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 0.441M |
| October 08, 2026 | 0.441M |
| October 07, 2026 | 0.441M |
| October 06, 2026 | 0.441M |
| October 05, 2026 | 0.441M |
| October 02, 2026 | 0.441M |
| October 01, 2026 | 0.441M |
| September 30, 2026 | 0.441M |
| September 29, 2026 | 0.441M |
| September 28, 2026 | 0.441M |
| September 25, 2026 | 0.441M |
| September 24, 2026 | 0.441M |
| September 23, 2026 | 0.2756M |
| September 22, 2026 | 0.2756M |
| September 21, 2026 | 0.2756M |
| September 18, 2026 | 0.1654M |
| September 17, 2026 | 0.2205M |
| September 16, 2026 | 0.2205M |
| September 15, 2026 | 0.2205M |
| September 14, 2026 | 0.2205M |
| September 11, 2026 | 0.2205M |
| September 10, 2026 | 0.2205M |
| September 09, 2026 | 0.2756M |
| September 08, 2026 | 0.2205M |
| September 04, 2026 | 0.3308M |
| Date | Value |
|---|---|
| September 03, 2026 | 0.3308M |
| September 02, 2026 | 0.3308M |
| September 01, 2026 | 0.3308M |
| August 31, 2026 | 0.2756M |
| August 28, 2026 | 0.2756M |
| August 27, 2026 | 0.2756M |
| August 26, 2026 | 0.4962M |
| August 25, 2026 | 0.3859M |
| August 24, 2026 | 0.441M |
| August 21, 2026 | 0.441M |
| August 20, 2026 | 0.441M |
| August 19, 2026 | 0.441M |
| August 18, 2026 | 0.441M |
| August 17, 2026 | 0.3859M |
| August 14, 2026 | 0.3859M |
| August 13, 2026 | 0.3859M |
| August 12, 2026 | 0.2756M |
| August 11, 2026 | 0.2205M |
| August 10, 2026 | 0.2205M |
| August 07, 2026 | 0.2756M |
| August 06, 2026 | 0.2756M |
| August 05, 2026 | 0.3308M |
| August 04, 2026 | 0.3308M |
| August 03, 2026 | 0.2756M |
| July 31, 2026 | 0.2756M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.011B |
| Vericel Corp. | 2.052B |
Market Cap Related Metrics
| Price | 0.0008 |